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Infections Associated with Substance Use and Related Behaviors
Introduction
Over the last several years, there has been an 
increasing interest in the clinical implementation 
of multidisciplinary endocarditis teams.1 Since 
the first publication in 2009 demonstrating the 
mortality benefits associated with such groups, 
they have become the standard of care for the 
diagnosis and management of endocarditis at 
European tertiary care medical centers.2,3 
Adoption of this coordinated approach has been 
slower in North America, although one recent 
study from the University of Michigan demon-
strated a dramatic reduction in in-hospital endo-
carditis mortality after the implementation of a 
multidisciplinary endocarditis team.4 In addition, 
the increase in endocarditis associated with the 
opioid epidemic has sparked interest in develop-
ing a similar model of care in the United States.5,6 
Several publications have discussed the basic 
organization and structure of such groups. These 
papers have included direction regarding which 
specialists should be involved, how referrals from 
transferring hospitals should be coordinated and 
the role of the team in participating in clinical 
research.1,7 However, there has been little 
discussion about the logistics behind how a large 
institution transforms its endocarditis practice 
from a fragmented, disjointed process to an effi-
cient, collaborative care model. Moreover, the 
majority of previous publications on this topic 
have come from European centers. While there 
are undoubtedly many areas of overlap, the 
American and European systems of health care 
have substantial differences that impact the effec-
tive development of these groups. In this piece, 
the authors will discuss the step-by-step approach 
they took to creating a successful multidiscipli-
nary endocarditis team at the University of 
Michigan (Figure 1).4
Phase I: identify the clinical leader(s)
One of the most important components of this 
process is identifying who will coordinate and 
lead a newly formed multidisciplinary endocardi-
tis team. Having designated leadership is crucial 
for recruitment of team members, reviewing 
existing outcomes (see Phase II), organizing and 
moderating meetings and directing research. It is 
also helpful to have a ‘point person’ for other 
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providers and administrators at an institution to 
contact with questions about endocarditis. The 
leadership can also apply for institutional review 
board (IRB) approval for review of retrospective 
data and future team research projects. Depending 
on the hospital, there may be funding available 
for such a position. However, in practice these, 
efforts often develop without financial support. 
Ideally, the multidisciplinary team will be led by 
1–2 individuals who are principally involved in 
the care of patients with endocarditis at the insti-
tution. Infectious disease (ID) providers are well 
suited for this role as every patient with endocar-
ditis requires antibiotic therapy, and ID consulta-
tion has been shown to improve mortality in 
multiple types of blood stream infections.8,9 
However, cardiac surgeons, cardiologists and 
hospitalists are also good candidates for this posi-
tion. In some circumstances, medical residents or 
fellows can play a significant role as they are well-
versed in hospital workflow and may have pro-
tected research time they can devote to the 
project.10 If the development of an endocarditis 
team is driven by the hospital administration, 
then the team leadership may be appointed. In 
the absence of such a directive, then the clinical 
leads are often the individuals who are most pas-
sionate about improving the care of the patients 
with endocarditis or have clinical or research 
interests in this domain.
Phase II: identify the problem(s)
A crucial early step is understanding the popula-
tion of patients with endocarditis that an individ-
ual institution cares for and what their clinical 
outcomes are relative to national numbers. In the 
United States, the in-hospital mortality for infec-
tious endocarditis is reported as ranging from 
15% to 20%, but theses outcomes may vary 
between regions and medical centers.11 Utilizing 
an internal data collection tool, the authors per-
formed a retrospective chart review of all endo-
carditis admissions to their institution over a 
1-year period in order to help better understand 
the patient population and its needs.4 A develop-
ing endocarditis team should understand its own 
institution’s mortality outcomes and attempt to 
identify which variables contribute to these 
results. For example, it is important to determine 
whether a significant proportion of the hospital’s 
patients with endocarditis are individuals who 
Figure 1. Graphic overview of the authors’ step-by-step approach to developing a multidisciplinary 
endocarditis team.
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inject drugs. This will help inform the future 
composition of the team as addiction medicine/
psychiatry and social work play critical roles in 
caring for this population.12 If these providers are 
not already available at an institution, endocardi-
tis team members can advocate for their hospital 
to acquire more addiction treatment resources.
There are myriad challenges associated with car-
ing for all patients with endocarditis with many 
opportunities for interruptions in care. During 
preliminary meetings, the authors used a quality 
improvement informed approach to create a ‘fish-
bone diagram’ that identified factors contributing 
to delays in care or adverse outcomes (Figure 2).13 
As highlighted in Figure 2, delays may occur in 
obtaining certain diagnostic testing, such as 
transesophageal echocardiography, magnetic res-
onance imaging, or coronary angiography.14 At 
the authors institution most patients with endo-
carditis are admitted as outside hospital referrals 
for surgical evaluation. However, many of these 
transfers happen on Friday evenings due to bed 
availability. Endocarditis admissions occurring 
over the weekend have notably been associated 
with adverse outcomes.15 Consequently, the 
authors’ endocarditis team scheduled meetings 
on Monday mornings to ensure that all patients 
presenting over the weekends were discussed by 
the group in a timely fashion. In addition, medi-
cal providers may not always be aware of endo-
carditis surgical indications or may feel that 
patients are unlikely to be offered surgery. This 
may result in delays in or the absence of cardiac 
surgical consultation which can in-turn serve to 
increase in-hospital mortality as early surgical 
intervention is associated with improved clinical 
outcomes.16–18 At our institution, these obstacles 
were overcome by hiring an advanced practice 
provider (APP) to increase the capacity of the car-
diac surgery department to see new consults and 
by development of a best practice advisory in the 
electronic medical record that suggested a cardiac 
surgery consultation to providers whenever a 
diagnosis of endocarditis was made.
Phase III: recruiting team members
After a leadership structure has been identified 
and existing outcomes are reviewed, the next 
phase involves recruitment of the other key team 
members. Previous studies have highlighted that 
an effective multidisciplinary endocarditis team 
should include representatives from ID, cardiac 
surgery, cardiology (including cardiologists with 
expertise in echocardiography and electrophysiol-
ogy), neurology and/or neurosurgery, and phar-
macy (Table 1).1,2 Inclusion of addiction medicine/
Figure 2. Fishbone diagram created by members of the University of Michigan Multidisciplinary Endocarditis 
Team outlining potential factors contributing to increased mortality for patients with endocarditis.
Therapeutic Advances in Infectious Disease 8
4 journals.sagepub.com/home/tai
psychiatry and social work is also imperative as 
almost all referral centers will care for patients 
with injection drug use associated endocarditis.12 
If the hospital has an outpatient antimicrobial 
treatment program, it may be beneficial to include 
these providers as well. Although not every patient 
with endocarditis will have an indication for valve 
surgery initially, they may develop indications 
subsequently. In addition, cardiac surgeons pro-
vide valuable experience and perspective when 
considering complex valvular pathology as evi-
denced by their inclusion in heart valve teams.19 
Neurology and neurosurgery participation could 
be limited to instances when patients have a neu-
rologic complication of endocarditis.
The identification of team members may be chal-
lenging, given that in most circumstances, there is 
no financial reimbursement to providers for the 
time commitment associated with participation. 
There can be multiple effective strategies for 
recruiting providers from the various necessary 
specialties. If the endocarditis team leader(s) are 
well known in the hospital, then direct communi-
cation with a colleague is a straightforward and 
expedient approach. However, if the leadership is 
relatively new to the medical center, then it may 
be prudent to have these individuals present the 
existing endocarditis data and the benefits of mul-
tidisciplinary endocarditis teams to the various 
specialties at a regularly scheduled departmental 
meeting. The authors both directly contacted 
providers with whom they had existing relation-
ships and presented at the monthly faculty meet-
ings for the divisions of cardiology, infectious 
diseases, and the department of cardiac surgery. 
If possible, teams should seek to involve 2–3 spe-
cialists from each department to ensure that con-
sistent representation is not dependent on the 
availability of one person. The authors would also 
recommend including any APPs that work closely 
with physicians in the designated specialties.
Table 1. Roles and recommended attendance of the specialties comprising a multidisciplinary endocarditis team.
Specialty Role Recommended attendance
Infectious diseases 1. Case ascertainment
2. Screen patients for substance use disorder
3. Selection of antibiotic regimen and duration
4. Coordinate outpatient follow-up
All meetings
Cardiology 1.  Review echocardiographic and angiographic 
imaging
2.  Provide recommendations for and interpretation 
of advanced cardiac imaging modalities (i.e., PET)
3. Recommendations regarding follow-up imaging
All meetings
Cardiac Surgery 1. Evaluate and select patients for valve surgery
2.  Recommendations regarding pre-operative 
testing
3. Recommendations regarding follow-up
All meetings
Pharmacy 1.  Recommendations about optimal dosing of 
antimicrobial
All meetings
Neurology 1. Recommendations about neurologic imaging
2.  Recommendations about the timing of anti-
coagulation in patients undergoing valve surgery
As needed – for patients with known 
neurologic complications of endocarditis
Neurosurgery 1.  Screening and management of mycotic 
aneurysms
As needed – for patients with known 
neurologic complications of endocarditis
Addiction medicine/psychiatry 1.  Initiation of medication assisted treatment for 
substance use disorder
2.  Link patients to outpatient programs for ongoing 
treatment
As needed – for patients with substance 
use disorder complicating the diagnosis of 
endocarditis
PET, positron-emission tomography.
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Phase IV: scheduling the meetings/choosing 
a location
Scheduling a meeting may seem like a mundane, 
straightforward task that should not require much 
discussion. However, an effective endocarditis 
team is comprised of upwards of 10 medical pro-
viders who have numerous competing clinical and 
research responsibilities. While all providers are 
important to the success of the team, cardiac sur-
gery is the most specialized of the involved disci-
plines and is closely associated with improved 
endocarditis survival.16–18 In addition, surgeons 
often have limited availability for such interdiscipli-
nary work, given their responsibilities in the operat-
ing room. Therefore, the authors would recommend 
scheduling the meetings to accommodate as many 
cardiac surgeons as possible. This will require other 
team members to also acknowledge the prominent 
role of cardiac surgery. The day(s) of the week the 
meeting is held can also have significant impact on 
the team’s effectiveness. As alluded to previously, 
at the authors institution many patients are admit-
ted over the weekend, prompting the scheduling of 
one team meeting on Monday mornings. The 
authors would recommend against holding confer-
ences on Fridays as it may be challenging for team 
recommendations to be implemented prior to and 
over the weekend. Depending on the clinical vol-
ume some hospitals may find it necessary to meet 
for 30 or 60 minutes and to hold more than 1 meet-
ing per week. Ad hoc meetings can be considered 
but may be hard to implement, given the busy prac-
tices of the involved clinicians. One advantage of 
the multidisciplinary endocarditis team is that it 
fosters familiarity between providers which can 
allow for increased communication regarding 
patient care outside of scheduled meetings, such as 
via phone call or e-mail.
With respect to choosing a designated meeting 
place, again it may be practical to select a location 
in close proximity to the surgery departmental 
offices. The ideal space has the capacity to seat 
15–20 people with audio-visual capabilities, 
including access to echocardiographic and coro-
nary angiographic images so that they may be 
reviewed by team specialists. Ultimately, the 
authors elected to hold their meeting in the car-
diac surgery conference room adjacent to the sur-
geons’ offices. Generally, the authors recommend 
that the endocarditis team meet in-person to 
allow providers to build rapport with one another 
and to avoid miscommunications or interpersonal 
conflict. However, providing a virtual meeting 
option may also allow for increased attendance 
and social distancing if necessary.
Phase V: developing a protocol
Once the key team members have been selected 
and a designated meeting time and location are 
chosen, initial discussions would ideally focus on 
developing an institutional protocol for manage-
ment of endocarditis cases. Although there are 
consensus endocarditis management guidelines 
published by the American Heart Association and 
the European Society of Cardiology (ESC), there 
are also notable gaps in these resources.3,20 
Among these are issues surrounding the manage-
ment of patients with injection drug use associ-
ated endocarditis. In addition, the broader 
medical endocarditis literature is limited by a 
dearth of randomized controlled trial in this 
patient population. Consequently, there is signifi-
cant provider-dependent variability with respect 
to management recommendations, particularly 
surrounding decisions regarding echocardio-
graphic imaging, surgery, and neurologic compli-
cations of endocarditis. Such protocols have 
correlated with the improvement in clinical out-
comes described in previous studies.2 While there 
are some aspects of endocarditis patient care that 
are consistent among hospitals, each institution 
has its own unique patient population as well as 
strengths and weaknesses. For example, positron-
emission tomography (PET) is endorsed by the 
ESC guideline as an important adjunctive tool for 
diagnosing endocarditis.3 However, many centers 
do not have clinical cardiac PET programs avail-
able to them. The multidisciplinary endocarditis 
team, supported by internal data (see Phase II), is 
best equipped to tailor a protocol unique to their 
hospital. After creation of their endocarditis team, 
the authors spent the first month of their group’s 
meetings developing a protocol which provided 
guidance about initial laboratory and imaging 
evaluation in suspected endocarditis, when to 
pursue advanced cardiac imaging modalities, how 
to screen for substance use disorders and when to 
involve addiction treatment providers, recom-
mendations about neurologic imaging and when 
to pursue medical or surgical management. The 
authors’ full protocol has been previously pub-
lished elsewhere.4 Once a consensus document is 
created and approved by team members, the 
authors would recommend that the group makes 
the algorithm publicly available to all health care 
providers within their institution.
Therapeutic Advances in Infectious Disease 8
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Phase VI: case identification
In general, all cases of definite endocarditis as 
defined by the modified Duke Criteria should be 
presented for discussion by the multidisciplinary 
endocarditis team.21 The authors would also sug-
gest that the group present patients with possible 
endocarditis, particularly if a valve vegetation is 
present, given the relative insensitivity of the 
Duke Criteria.22 It is also reasonable for the team 
to consider cases where the diagnosis is uncertain 
at the request of the patient’s primary medical 
providers. The process of ascertaining endocardi-
tis cases for presentation at regular gatherings of 
the endocarditis team may vary considerably 
between hospitals. Team leaders can consider dif-
ferent approaches based on their center’s internal 
workflow. Methods for identifying patients can 
include utilizing the ID consult service (the 
authors’ approach) as the majority of, if not all, 
patients with endocarditis will receive ID consul-
tation. Depending on the volume of patients, the 
ID division may consider dedicating one of their 
consult services specifically to patients with endo-
carditis. The cardiac surgery consult team may 
also capture patients who are not identified by 
ID. Alternatively, patients can be found using 
ICD diagnosis codes. However, this approach 
may result in detection of an excess number of 
patients including those with a history of endo-
carditis that is not relevant to their current pres-
entation. If this strategy is selected, the 
endocarditis team would then have to review each 
case to ensure they are appropriate for discussion. 
A formalized referral process could be considered 
but would require the presence of individuals who 
can review and triage patient cases.
Phase VII: conducting the meetings/case 
presentations
After recruiting members, agreeing to a standard-
ized protocol and determining a method of case 
identification, the team is now positioned to begin 
presenting patient cases. There is no literature to 
support the best method for how to review 
patients. However, the authors have found from 
personal experience that certain practices may 
improve the caliber of the team’s discussion and 
the effectiveness of the meetings. First, the team 
leads should contact the group with a list of 
patients to be presented approximately 24 hours 
before the meeting. This will allow team mem-
bers who are not directly involved in a patient’s 
care to review the case details in advance. For 
example, a neurologist can review patient imaging 
and provide recommendations via email about 
timing of anti-coagulation prior to the meeting. 
The authors also recommend that the endocardi-
tis team invite providers from patients’ primary 
teams to the conferences as well as any consult-
ants that may not be team members but whose 
input will directly impact management (for exam-
ple, including a hepatologist for a patient with cir-
rhosis). It may be helpful to have a designated 
physician or APP moderator who facilitates the 
conversation and calls on specialists to give their 
input on pertinent clinical questions. This indi-
vidual can also prepare a brief visual presentation 
that includes background on the patient’s medi-
cal, surgical and social history as well as the results 
of validated surgical and embolism risk calcula-
tors.23,24 This presentation would ideally also 
include pertinent radiologic, echocardiographic, 
and angiographic images. After hearing input 
from team members, the moderator can then help 
summarize the discussion and push the group 
toward making a final recommendation. The 
team can also use its meetings as an internal mor-
bidity and mortality conference to review adverse 
events or poor outcomes, thereby continuing pro-
cess improvements on a regular basis.
Phase VIII: documenting and  
communicating recommendations
A critical component of a successful endocarditis 
team is efficient and clear documentation of rec-
ommendations. Although providers cannot bill 
for their involvement with these meetings, the 
communication of recommendations through the 
medical record allows providers who are unable 
to attend the meetings to reference the discus-
sion. Documentation is ideally completed by one 
of the team leads or the meeting moderator. A 
previous survey of providers at the authors’ insti-
tution found that a majority of health care provid-
ers felt the implementation of a multidisciplinary 
endocarditis team led to improved documenta-
tion of clinical recommendations.25 Since the 
note is not being utilized for billing purposes, it 
can focus explicitly on the medical decision-mak-
ing. For future research purposes, it may be use-
ful for the team to document in their note 
important features of the case including the Duke 
Criteria, type and location of the involved valve, 
etiologic organism, echocardiographic and radio-
logic findings as well as surgical and embolism 
risk calculations. Ideally, primary team members 
S El-Dalati, D Cronin et al.
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will attend the multidisciplinary discussion. 
However, if they are unable due to their other 
clinical responsibilities the authors suggest that 
an endocarditis team member convey the recom-
mendations either in-person or by phone.
Phase IX: maintaining a  
database/applying for funding
In order to demonstrate its clinical benefit, the 
multidisciplinary endocarditis team should longi-
tudinally follow their patients with an institutional 
registry. As discussed earlier, the team leadership 
can apply for IRB approval to store patient infor-
mation and review mortality. Collection of a 
broad range of demographic, clinical, microbio-
logic, echocardiographic, and outcome-related 
variables will help the team understand how it is 
affecting patient care and creates substantial 
research opportunities.4 Although dedicated 
funding to support an endocarditis team may not 
be initially available, if the group can demonstrate 
decreases in mortality, length of stay, readmis-
sions, or antibiotic usage then they can petition 
their hospital for financial support as a cost-sav-
ing measure. Assessment of clinicians’ percep-
tions of the endocarditis team can also help guide 
future team decisions. A survey of providers at 
the authors’ institution demonstrated that over 
85% of respondents agreed that the group influ-
enced diagnostic evaluation, reduced manage-
ment errors, increased access to surgery, and 
decreased in-hospital mortality for patients with 
endocarditis.25 In addition, once the team has 
collected sufficient data it can apply for external 
research grant funding. With dedicated resources 
the multidisciplinary endocarditis team could 
expand its reach, by offering virtual consultation 
to providers at smaller hospitals within a given 
healthcare network, as recommend by the ESC 
guidelines.3
Conclusion
While the clinical benefits of multidisciplinary 
endocarditis teams are well-established, creation 
of an effective, consistent collaboration between 
multiple specialties can be challenging to 
accomplish. There are numerous variables to con-
sider, any of which can derail this promising initia-
tive. Despite the inclusion of endocarditis teams in 
the ESC guidelines, there has been little direction 
provided to clinicians about how to best construct 
and operate these groups. In this paper, the 
authors have used their own data-supported per-
sonal experiences as well as available data to out-
line a step-by-step guide to creation of a successful 
multidisciplinary endocarditis team. In conjunc-
tion with existing literature, this piece can be used 
as a resource for clinicians seeking to improve the 
care of patients with endocarditis at their 
institutions.
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